DeSantis Pushes Back On Biden Administration Cutting Back on COVID-19 Antibody Infusion Supply

Governor Ron DeSantis is pushing back on the Biden team and their flawed logic. The Governor of Florida is not pleased with the current state of affairs. Here’s the deal, the Regeneron anti-body infusion project has been a significant boon to the fight against COVID-19. To be clear, it is not merely Regeneron but other firms who also supply the medication.

The projects work as such, if individuals are able to notice their COVID-19 status as soon as possible, then they can check into one of these anti-body infusion sites.

The medical personnel at the antibody infusion location will check their vitals, their unique situation, and provide them with the antibody therapy that they need if they meet the requirements. These sites are present in places that range from Florida to Louisiana.

Guess what? The anti-body infusion treatments are working. Many patients who obtain this treatment are able to get better and typically do not need further treatments. This means that they do not have to go to the ER. This means that you can catch it, solve it, and minimize it. Individuals could feel as if they have more options and can minimize their fear.

But there is a significant problem.

The Biden team wants to stop this successful operation that is quickly scaling up.

The Biden team noted recently said that they would reduce the total supply of monoclonal antibody treatments to Florida by over 45%. This is a significant deal. Why are you stopping something that works? These treatments help in West Palm Beach, Fort Pierce, and other locations to minimize the need for them to go to the ER. If they obtain these treatments, they are very likely to minimize their visits to the ER.

It makes no sense.

Florida and COVID-19 Antibody Infusion Supply

DeSantis noted that over 80,000 monoclonal antibody treatments have been provided to residents in Florida. Further interference from the Federal government (the U.S Department of Health and Human Services) would be a significant issue in deploying these antibody measures.

“We are very, very concerned with the Biden Administration and the HHS’ recent, abrupt, sudden announcement that they are going to dramatically cut the number of monoclonal antibodies that are going to be sent to the state of Florida,” DeSantis noted.

The White House notes that it is taking over supply and distribution because it wants to conduct equitable treatments in the US. That is plain nonsense. The terms “equity” and “equitable distribution” are thrown around more by the current leaders but it usually leads to more government incompetence and centralization of control.

“To just kind of pull the rug out from everyone a week after the president himself said they were going to be increasing the distributions by 50%, it’s very, very problematic,” DeSantis said.